GMAB

Genmab A/S ADS
D

GMAB

Arincen61/100B

Genmab A cash flow statement 2002–2026

Genmab A/S ADS's free cash flow over the last twelve months was 842.34M USD: operating cash flow of 874.35M USD less 32.00M USD of capital spending. That is 19.6% of its revenue and 1.32 a share.

Operating cash flow Free cash flow

Click a line's chart icon in the table to add it to the chart; hover over it for a quick look.

Fiscal year
TTM
30 Sept 2026
FY2025
31 Dec 2025
FY2024
31 Dec 2024
FY2023
31 Dec 2023
FY2022
31 Dec 2022
FY2021
31 Dec 2021
FY2020
31 Dec 2020
FY2019
31 Dec 2019
FY2018
31 Dec 2018
FY2017
31 Dec 2017
FY2016
31 Dec 2016
Net income
733.10M963.76M7.84B5.64B7.04B3.98B4.76B2.86B1.61B1.06B1.13B
Depreciation and amortization
—71.06M413.00M293.62M362.00M248.99M259.00M139.00M88.00M70.00M40.96M
Stock-based compensation
—0.00721.00M586.00M439.00M310.00M200.00M147.00M90.76M75.99M53.19M
Change in working capital
-101.19M225.18M-1.60B1.36B-1.93B-770.00M306.00M-1.22B-634.37M270.35M-794.94M
Change in receivables
-154.32M-166.13M-1.59B797.00M-2.12B-1.07B306.00M-1.66B-768.15M270.35M-794.94M
Change in inventory
-42.01M-9.01M-5.00M-57.00M0.000.000.000.000.000.000.00
Change in payables
—400.32M0.00622.00M283.00M304.00M0.00440.00M133.78M0.000.00
Change in other working capital
—0.000.000.00-90.00M0.000.000.000.000.000.00
Other non-cash items
114.44M-73.06M388.00M-620.62M-1.99B-997.99M910.00M-216.00M-232.09M249.50M-141.32M
Operating cash flow
874.35M1.19B7.77B7.38B3.91B2.23B6.43B1.33B1.01B1.59B327.72M
Operating cash flow growth
-27.82%-84.73%+5.30%+88.65%+75.58%-65.37%+385.14%+30.67%-36.14%+384.86%+5.22%
Capital expenditure
-32.00M-37.03M-187.00M-376.00M-317.00M-252.00M-307.00M-111.00M-477.37M-88.51M-33.11M
Acquisitions
—-7.22B-12.25B0.002.44B709.00M0.0032.00M405.67M0.0020.86M
Purchases of investments
—-995.78M-8.64B-10.91B-9.70B-15.62B0.00-5.81B-3.52B-3.43B-3.01B
Sales and maturities of investments
—2.62B11.28B10.00B7.25B14.91B0.003.94B2.22B2.85B2.03B
Other investing
—0.00-117.00M-10.00M-2.44B-709.00M-2.04B-32.00M-405.67M0.00-20.86M
Investing cash flow
-5.59B-5.65B-9.91B-1.28B-2.76B-961.00M-2.35B-1.98B-1.78B-667.57M-1.01B
Debt issued (repaid)
-298.31M5.23B-60.00M-91.00M-73.00M-58.00M-44.00M-31.00M0.000.00-118.00K
Shares issued
23.00M23.02M0.000.000.000.000.003.87B0.00203.44M819.00K
Share buybacks
—-430.34M-3.99B-564.00M-908.00M-447.00M-25.00M0.00-146.00M0.00-118.10M
Dividends paid
—0.000.000.000.000.000.000.000.000.000.00
Other financing
—-31.02M129.00M49.00M192.00M85.00M140.00M-182.00M75.10M11.47M209.41M
Financing cash flow
4.83B4.79B-3.92B-606.00M-789.00M-420.00M71.00M3.66B-70.90M214.91M91.19M
Net change in cash
99.09M345.33M-5.01B4.97B936.00M1.70B3.71B3.02B-814.64M1.04B-566.96M
Free cash flow
842.34M1.15B7.58B7.00B3.60B1.98B6.13B1.22B537.42M1.50B294.61M
Free cash flow growth
-26.27%-84.84%+8.28%+94.83%+81.93%-67.74%+404.20%+126.08%-64.18%+409.30%+67.34%
Free cash flow margin
19.61%30.89%35.23%42.52%24.78%23.48%60.59%22.64%17.77%63.43%16.22%
Free cash flow per share
1.321.8311.7310.635.452.999.301.910.872.420.48
Free cash flow per share growth
-27.06%-84.37%+10.43%+95.11%+82.03%-67.82%+386.99%+120.42%-64.15%+406.61%+64.65%
Interest paid
——35.00M———20.00M————
Income taxes paid
—0.000.000.000.000.000.000.000.000.000.00

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

Common questions about Genmab A's cash flow

Source: Financial Modeling Prep